Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus
- 1 May 2000
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 25 (1) , 42-46
- https://doi.org/10.1038/75578
Abstract
Char syndrome is an autosomal dominant trait characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies. Using a positional candidacy strategy, we mapped TFAP2B, encoding a transcription factor expressed in neural crest cells, to the Char syndrome critical region and identified missense mutations altering conserved residues in two affected families. Mutant TFAP2B proteins dimerized properly in vitro, but showed abnormal binding to TFAP2 target sequence. Dimerization of both mutants with normal TFAP2B adversely affected transactivation, demonstrating a dominant-negative mechanism. Our work shows that TFAP2B has a role in ductal, facial and limb development and suggests that Char syndrome results from derangement of neural-crest-cell derivatives.Keywords
This publication has 31 references indexed in Scilit:
- Char Syndrome, an Inherited Disorder With Patent Ductus Arteriosus, Maps to Chromosome 6p12-p21Circulation, 1999
- PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activationNucleic Acids Research, 1999
- Coactivator PC4 Mediates AP-2 Transcriptional Activity and Suppresses ras-Induced Transformation Dependent on AP-2 Transcriptional InterferenceMolecular and Cellular Biology, 1999
- Cloning and characterization of a second AP-2 transcription factor: AP-2βDevelopment, 1995
- A large family with patent ductus arteriosus and unusual face.Journal of Medical Genetics, 1993
- Analysis of the DNA-binding and activation properties of the human transcription factor AP-2.Genes & Development, 1991
- Characterization of a Dimerization Motif in AP-2 and Its Function in Heterologous DNA-Binding ProteinsScience, 1991
- Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis.Genes & Development, 1991
- Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers.Genes & Development, 1989
- Update on counseling the family with a first‐degree relative with a congenital heart defectAmerican Journal of Medical Genetics, 1988